SCHEMBL9574758

SCHEMBL9574758

O=C(NCCO)Oc1ccc(NS(=O)(=O)c2ccc(Oc3cccc(C(F)(F)F)c3)cc2)cn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.49
▸ PGR P06401 1/20 0.49
▸ AR P10275 1/20 0.49
▸ ESR2 Q92731 1/20 0.49
▸ GAA P10253 4/20 0.47
▸ RAB9A P51151 1/20 0.45
▸ MAPT P10636 4/20 0.44
▸ L3MBTL1 Q9Y468 3/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ CDK8 P49336 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ XBP1 P17861 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9574828 0.89 NR3C1 (0.48) NR3C1PGRARESR2GAA
SCHEMBL8869093 0.87 NR3C1 (0.52) NR3C1PGRARESR2GAA
SCHEMBL7870464 0.87 BCL2L1 (0.45) GAARAB9AMAPTL3MBTL1ALDH1A1
SCHEMBL9574909 0.81 HTT (0.44) ARMAPTALDH1A1KMT2AMEN1
SCHEMBL8868444 0.80 KDR (0.49) NR3C1PGRARESR2GAA
SCHEMBL9574745 0.79 SMN1; SMN2 (0.39) ARALDH1A1KMT2AMEN1LMNA
SCHEMBL8869647 0.79 PGR (0.50) NR3C1PGRARESR2GAA
SCHEMBL9574724 0.78 PGR (0.50) PGRALDH1A1KDM4EKMT2AMEN1
SCHEMBL9574705 0.76 CACNA1B (0.46) PGRRAB9AMAPTALDH1A1TDP1
SCHEMBL9574732 0.74 SMN1; SMN2 (0.45) RAB9AALDH1A1KDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 — — EP disclosed
Send feedback